News
Le Pr Etienne Chatelut nommé « co-editor » de Cancer Chemotherapy and Pharmacology
Le Pr Etienne Chatelut nommé « co-editor » de Cancer Chemotherapy and Pharmacology
La revue Cancer Chemotherapy and Pharmacology vient de désigner le Pr Etienne Chatelut comme « co-editor » de la publication. Seuls deux éditeurs, l’un nord-américain, l’autre européen, sont chargés de sélectionner les articles à publier dans la revue à l’échelle internationale.
Cancer Chemotherapy and Pharmacology est une revue scientifique reconnue spécialisée en pharmacologie cancérologique.
The cancer biology laboratory
The laboratory includes biochemical tumor markers, pharmacology-pharmacokinetics and molecular oncology activities, and develops research programs.
Head of the Laboratory : Prof. Gilles Favre
Biological engineer : Christine Toulas
Secretary: 05 31 15 52 01
- Biochemistry-tumor markers division
- Biochemistry tests
- tumor markers associated with the establishment of the biological resources center
- biological support for clinical investigations and constitution of biological fluids for the biological resources center
- discovery and validation of biomarkers.
- Pharmacology division
- pharmacokinetics
- assay of cancer treatment drugs
- Molecular oncology division
- molecular oncogenetics combined with oncogenetic appointments,
- pharmacogenetics activity,
- development of translational research activity in oncogenetics.
The pharmacology laboratory handles therapeutic monitoring activities and has a support function for the regional and national research teams.
Pharmacology is a scientific speciality that studies the mechanisms of interaction between an active substance such as a drug molecule and the body in which it is active. Therapeutic drug monitoring consists of measuring circulating plasma concentrations of a drug to ensure it is properly eliminated from the body, or that the measured concentration matches the expected therapeutic level.